For Doctors

Home

›

For doctors

For Doctors

Referring & prescribing information

Background

Endocannabinoid support therapy became legal for prescription in Australia in October 2016 as legislated by the Therapeutic Goods Administration (TGA). Healthcare practitioners can prescribe this treatment option to patients through SAS-B application to the TGA or as an Approved Prescriber (AP) – as a second line treatment option where previous medication options and treatment modalities have not offered suitable outcomes.

Why refer your patient

Why refer your patient? Our healthcare professionals specialise in endocannabinoid support treatment. With extensive experience in applying this treatment modality, we will work in a shared care role to ensure your patient receives the right treatment for their health concerns. If you would like to refer your patient, our team of healthcare professionals will work alongside you to provide your patient with appropriate and complementary treatment.

Is this treatment suitable for my patient?

Evidence has shown that endocannabinoid support treatment has been effective in treating and reducing the symptoms of various chronic health concerns including chronic pain, emotional concerns, nausea and vomiting, menstrual pain and more.

While there are numerous traditional options for these conditions, patients have found various side effects which outweigh the benefits or long term use of these treatments.

Endocannabinoid support treatment has shown potential as an alternative treatment where traditional treatments have failed. Learn more at the Therapeutic Goods Administration.